학술논문
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Document Type
Article
Author
Cavalli-Björkman, Carin; Björklund, Astrid; Hune, Britt-Marie; Clements, Mark; Hao, Shuang; Discacciati, Andrea; Grönberg, Henrik; Eklund, Martin; Nordström, Tobias; Carlsson, Stefan; Aly, Markus; Walldén, Mats; Steinberg, Ola; Andersson, Karl; Jäderling, Fredrik; Wimmercranz, Fredrik; Meurling, Edward; Gleassgen, Axel; Majeed, Nada; Awadelkarim, Rihab; Fyhr, Ing-Marie; Sandström, Dag; Waage, Linda; Imamov, Otabek; Lantz, Rafael; Thorstensson, Andreas; Stiernstedt, Carl; Wande, Dushaid; Trygg, Gunnar; Söderbäck, Harald; Michajlowski, Jerzy; Leykamm, Lars; Svedberg, Nils-Erik; Bergman, Tommy; Sabockis, Raimundas; Akrawi, Sirvan; Bergman, Martin; Annerstedt, Magnus; Glaessgen, Axel
Source
In The Lancet Oncology September 2021 22(9):1240-1249
Subject
Language
ISSN
1470-2045